We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Tries to Influence Market With Head-to-Head Drug Study
GSK Tries to Influence Market With Head-to-Head Drug Study
January 26, 2007
GlaxoSmithKline (GSK) will undertake a head-to-head study of its candidate to prevent cervical cancer against Merck’s drug Gardasil in an effort to sway the market, GSK said.